Regenerative biologics supplier for orthopedic practices in Davenport, IA

How orthopedic groups typically qualify a biologics supplier

Orthopedic practices and surgery centers that add Wharton's jelly allografts or exosome products to a vendor list generally start with the same questions: who is the distributor, what documentation backs each lot, and how is a shipment tracked once it arrives. A master distributor relationship means Precision Biologics sources from a single supplier and passes through the documentation that supplier provides for each lot.

Most practices route a new-vendor request through whoever manages purchasing and compliance for the group, then loop in the medical director before the first order is placed. That internal review is separate from anything Precision Biologics can speak to — it is the practice's own process for deciding which products fit its regulatory posture.

• Confirm the distributor and the product family (Wharton's jelly or extracellular vesicle/exosome)
• Request the certificate of analysis and donor eligibility summary for the specific lot
• Route the vendor review through your group's compliance or purchasing lead before ordering

NPI-verified accounts and ordering

Account setup requires an NPI number tied to a licensed clinic or physician, consistent with how Precision Biologics restricts sales to licensed healthcare professionals. Once an account is verified, ordering runs through the same channel for every product family, with pricing available to verified accounts rather than published publicly.

A staff member handling procurement can start the verification conversation and loop in the ordering physician once the account is active.

Cold-chain shipping into the Midwest

Cryopreserved Wharton's jelly products ship overnight on dry ice in validated containers, with storage held at -80 degrees C prior to shipment. Lyophilized formats are shelf-stable and do not require the same cold-chain handling, though they still arrive with a product insert covering storage and handling for that lot.

Clinics receiving a cryopreserved shipment should plan for someone to be available to receive and log the package on the day it is scheduled to arrive, regardless of time zone or regional carrier schedule.

Documentation and medical-director sign-off

Before placing a first order, most groups ask for the certificate of analysis, donor eligibility summary, and lot release record for the lot they intend to purchase, and confirm the regulatory posture of the intended use with their own medical director and legal counsel — Precision Biologics does not advise on clinical use, dosing, or procedures. Account teams can also arrange a peer-to-peer conversation between a Precision Biologics contact and the ordering physician focused on product documentation.

Verifying your own state licensure status with the Iowa medical board, and reviewing the regulatory framework for the specific product with counsel, are steps a practice completes independently of any supplier relationship.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.